10 records – page 1 of 1.

Select Title Policy Type Year
EspAddText
EspRemoveText
Policy Brief: CSAM-SMCA in Support of the Decriminalization of Drug Use and Possession for Personal Use Policy endorsement 2021
EspAddText
EspRemoveText
Excise duty framework for cannabis products Response to consultation 2017
EspAddText
EspRemoveText
Non-prescription availability of low-dose codeine products Response to consultation 2017
EspAddText
EspRemoveText
Bill C-45: The Cannabis Act Parliamentary submission 2017
EspAddText
EspRemoveText
CMA response to patented medicines regulations consultations Response to consultation 2017
EspAddText
EspRemoveText
Canada’s lower-risk cannabis use guidelines (LRCUG) Policy endorsement 2017
EspAddText
EspRemoveText
CMA’s Recommendations for Bill S-5: An Act to amend the Tobacco Act and the Non-smokers’ Health Act and to make consequential amendments to other Acts Parliamentary submission 2017
EspAddText
EspRemoveText
CMA submission to the study of Bill C-37 Parliamentary submission 2017
EspAddText
EspRemoveText
Consultation on the renewal of Federal Tobacco Control Strategy Response to consultation 2017
EspAddText
EspRemoveText
Position statement on prescription drug shortages in Canada Policy document 2017

10 records – page 1 of 1.